Results 141 to 150 of about 78,382 (206)

Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells. [PDF]

Cell Commun Signal
Németh A, Bányai GL, Dobos NK, Kós T, Gaál A, Varga Z, Buzás EI, Khamari D, Dank M, Takács I, Szász AM, Garay T.   +11 more
europepmc   +1 more source

Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD-1 antibody for BRAF-mutated melanoma. [PDF]

Cancer Sci
Nakamura K, Yaguchi T, Murata M, Ota Y, Mikoshiba A, Kiniwa Y, Okuyama R, Kawakami Y.   +7 more
europepmc   +1 more source

Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer. [PDF]

Gynecol Oncol Rep
Sama S, Rosqvist S, Savage T, Lomo L, Sibbald K, Straubhar A, Werner TL.   +6 more
europepmc   +1 more source

BRAF inhibitor candidate molecule usnic acid might use both intrinsic and extrinsic pathways of apoptosis. [PDF]

Turk J Med Sci
Büyük BP, Cansaran Duman D, Duman T.
europepmc   +1 more source

A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation. [PDF]

Cancer Discov
Yaeger R, McKean MA, Haq R, Beck JT, Taylor MH, Cohen JE, Bowles DW, Gadgeel SM, Mihalcioiu C, Papadopoulos KP, Diamond EL, Sturtz KB, Feng G, Drescher SK, Reddy MB, Sengupta B, Maity AK, Brown SA, Singh A, Brown EN, Baer BR, Wong J, Mou TC, Wu WI, Kahn DR, Gadal S, Rosen N, Gaudino JJ, Lee PA, Hartley DP, Rothenberg SM.   +30 more
europepmc   +1 more source

Comparative Analysis of the Effect of the BRAF Inhibitor Dabrafenib in 2D and 3D Cell Culture Models of Human Metastatic Melanoma Cells. [PDF]

In Vivo
Tovar-Parra D, Zammit-Mangion M.
europepmc   +1 more source

BRAF(V600E) Kinase Inhibitor RO5212054 [PDF]

, 2020
openaire   +1 more source

Addition of anti-PD-1 immunotherapy to BRAF inhibitor-based targeted therapy improves real-world survival and delays brain metastases in patients with BRAF^V600-mutant advanced melanoma: a multicenter cohort study. [PDF]

MedComm (2020)
Wu J, Ding Q, Zhang Q, Chen Q, Wen X, Ding Y, Li J, Chen Z, Zhang T, Wang J, Huang F, Jiang H, Chen L, Zhou Q, Li K, Zhang X, Li D.   +16 more
europepmc   +1 more source

Leser-Trélat sign on BRAF inhibitors

Annales de Dermatologie et de Vénéréologie
C, Decaestecker, R, Levard, J-M, L'Orphelin   +2 more
openaire   +2 more sources

BRAF/EGFR Inhibitor BGB-283 [PDF]

, 2020
openaire   +1 more source